reference/28328809

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/28328809

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase III\|Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	889
issn	1556-0864
issueIdentifier	6
pageRange	883-889
publicationName	Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
startingPage	883
bibliographicCitation	Geater SL, Xu CR, Zhou C, Hu CP, Feng J, Lu S, Huang Y, Li W, Hou M, Shi JH, Lee KY, Palmer M, Shi Y, Lungershausen J, Wu YL. Symptom and Quality of Life Improvement in LUX-Lung 6: An Open-Label Phase III Study of Afatinib Versus Cisplatin/Gemcitabine in Asian Patients With EGFR Mutation-Positive Advanced Non-small-cell Lung Cancer. J Thorac Oncol. 2015 Jun;10(6):883–9. doi: 10.1097/jto.0000000000000517. PMID: 25933111.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-9840-8199 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8661ed976a1d46c09c1ea82578698d74 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2af5ae69576bee295811375232421053 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0f2a532458eb21d2591d53143d44861b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9f2f201caceb57b0739887993774fed6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_98b0de0cf6408e365af368a48806b435 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_826fe2be8f9341d4c791d01baad591a5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a73a4957e5906f5bb6fe9674cf1eec44 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8a670aca48c4b6cfe9c806df2ddec7a4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3b60a5fe092010a0aab1d241889185e9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ab675e9c70e188e1bacf60b678a59620 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0f4385ffe6f2b7bc52fbc1a61037d516 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3611-0258 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_67f01922096949778d955308e78ab4b5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8801456b086a068a5b1545507d44380e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4e2f32ba4669f823005b42b057d4342b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_445c654b648495d3b87dbcd7fd58361d
date	201506
identifier	https://pubmed.ncbi.nlm.nih.gov/25933111 https://doi.org/10.1097/jto.0000000000000517
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/33311 https://portal.issn.org/resource/ISSN/1556-0864
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Symptom and Quality of Life Improvement in LUX-Lung 6: An Open-Label Phase III Study of Afatinib Versus Cisplatin/Gemcitabine in Asian Patients With EGFR Mutation-Positive Advanced Non–small-cell Lung Cancer
discusses	http://id.nlm.nih.gov/mesh/M000754277 http://id.nlm.nih.gov/mesh/M0005997 http://id.nlm.nih.gov/mesh/M0004505 http://id.nlm.nih.gov/mesh/M0500817 http://id.nlm.nih.gov/mesh/M0561143 http://id.nlm.nih.gov/mesh/M0018336 http://id.nlm.nih.gov/mesh/M0593322
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D008175Q000188 http://id.nlm.nih.gov/mesh/D011799Q000627 http://id.nlm.nih.gov/mesh/D066246Q000235 http://id.nlm.nih.gov/mesh/D044466Q000235 http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D002289Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D002289Q000235 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D008175Q000473 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D008175Q000201 http://id.nlm.nih.gov/mesh/D008175Q000235 http://id.nlm.nih.gov/mesh/D003841Q000031 http://id.nlm.nih.gov/mesh/D003841Q000008 http://id.nlm.nih.gov/mesh/D002945Q000008 http://id.nlm.nih.gov/mesh/D000077716 http://id.nlm.nih.gov/mesh/D000093542 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D009154 http://id.nlm.nih.gov/mesh/D018572 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D002289Q000473 http://id.nlm.nih.gov/mesh/D002289Q000201 http://id.nlm.nih.gov/mesh/D011788
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5702198 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fddb60309b0ee16f8cd57b4b90c99e89 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8366 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60750 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10184653

Total number of triples: 75.